Curcumin/Paclitaxel

姜黄素/紫杉醇

Report date: 2025/12/12 17:32:27

Base Information

Drug NameCurcumin/Paclitaxel
Drug Alias NamePaclitaxel/curcuminSTO-1
ClassificationSmall molecules
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitorsTubulin inhibitorsTubulin polymerisation promoters +[4] 
TargetsDNA (cytosine-5)-methyltransferase 1Tubulin
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes CurcuminPaclitaxel
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVascarta Inc
China Registration ClassN/A

Develop Information

Active CompaniesVascarta Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A